AbCellera Biologics Ratios (2020-2025) | ABCL

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 90.62%95.13%93.31%87.72%90.13%86.94%77.90%84.29%85.90%88.65%85.17%92.87%69.07%61.80%47.45%66.23%
EBT Margin -44.94%59.70%-28.77%77.52%79.65%-7.50%-453.38%60.80%72.91%-15.00%45.95%-145.80%-394.91%-377.92%-595.18%-529.49%
EBIT Margin -45.57%-7.61%-18.88%77.33%77.97%-25.44%-510.09%58.53%71.06%-18.29%37.22%-175.34%-532.10%-511.03%-831.79%-719.61%
EBITDA Margin -45.57%59.70%-28.77%56.28%57.82%-0.62%-415.54%42.76%53.41%-15.24%24.99%-141.88%-334.15%-302.37%-426.90%-516.51%
Operating Margin -45.57%-7.61%-18.88%77.33%77.97%-25.44%-510.09%58.53%71.06%-18.29%37.22%-175.34%-532.10%-511.03%-831.79%-719.61%
Net Margin -44.94%59.70%-28.77%56.28%57.82%-8.40%-388.16%43.03%53.25%-14.78%26.26%-138.75%-328.99%-303.58%-433.55%-513.67%
FCF Margin -28.92%198.38%-82.10%-0.11%52.23%437.29%-263.36%-18.76%27.08%526.37%-137.40%86.25%-484.31%-72.57%-309.70%-370.87%
Efficiency
Assets Average 1,067.03M1,140.19M1,162.29M1,245.65M1,455.43M1,593.04M1,573.10M1,546.66M1,519.41M1,517.54M1,524.68M1,500.14M1,475.60M1,437.79M1,402.65M1,376.69M1,352.38M1,373.13M1,379.03M
Equity Average 893.82M962.40M960.54M989.57M1,116.62M1,210.18M1,231.51M1,241.72M1,220.89M1,201.66M1,188.80M1,167.55M1,141.12M1,120.44M1,094.53M1,067.09M1,039.53M1,015.03M985.56M
Invested Capital 843.92M970.89M979.25M965.52M1,048.67M1,235.01M1,247.11M1,282.70M1,277.49M1,251.38M1,249.70M1,236.70M1,202.79M1,181.34M1,130.99M1,098.31M1,064.17M1,031.75M1,007.08M964.04M
Asset Utilization Ratio 0.400.390.380.300.340.320.380.310.120.100.030.030.020.010.01
Leverage & Solvency
Debt to Equity 0.020.010.010.010.020.020.030.030.040.040.050.050.040.050.020.020.010.01
Debt Ratio 0.010.010.010.010.020.020.020.020.030.030.040.040.030.040.010.010.010.01
Equity Ratio 0.830.850.840.810.780.760.760.810.800.810.780.780.770.770.790.770.780.760.720.71
Valuation
Enterprise Value -594.12M-685.79M-792.57M-517.69M-747.98M-786.05M-1022.27M-868.21M-911.49M-796.50M-795.69M-785.84M-785.59M-723.02M-695.36M-668.14M-650.61M-630.27M-578.08M-520.67M
Return Ratios
Return on Sales -0.45%0.60%-0.29%0.78%0.58%-0.08%-3.88%0.43%0.53%-0.15%0.26%-1.39%-3.29%-3.04%-4.34%-5.14%-4.11%-4.80%-5.14%
Return on Capital Employed 0.32%0.29%0.25%0.18%0.22%0.20%0.23%0.15%-0.05%-0.08%-0.15%-0.17%
Return on Invested Capital 0.14%0.17%0.15%0.19%0.11%-0.07%-0.10%-0.14%-0.16%
Return on Assets 0.26%0.24%0.22%0.12%0.14%0.13%0.16%0.10%-0.03%-0.05%-0.08%-0.10%-0.07%-0.05%-0.03%
Return on Equity 0.32%0.28%0.27%0.16%0.18%0.17%0.20%0.13%-0.04%-0.06%-0.11%-0.13%-0.09%-0.07%-0.04%